Samuel Verzosa
Internal Medicine · Bartlett, TNNPI 1730182882
Payments from drug & device makers
Across 520 payments — averaging $28.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- GSK$1K
- Novo Nordisk$1K
- Amgen$859
- Johnson & Johnson$835
- plus $7K from 28 others
What the payments were for
- Consulting fees$8005%
- Food & beverage$13,70094%
- Education$1451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 73 | $2,128 |
| AbbVie(2 entities) | 32 | $1,385 |
| GSK | 65 | $1,127 |
| Novo Nordisk | 47 | $1,043 |
| Amgen | 20 | $859 |
| Johnson & Johnson | 31 | $835 |
| Paratek Pharmaceuticals, Inc. | 2 | $812 |
| Boehringer Ingelheim | 31 | $784 |
| Amarin Pharma, Inc. | 38 | $777 |
| Esperion Therapeutics, Inc. | 14 | $747 |
| Bayer | 8 | $699 |
| Merck | 28 | $556 |
| Pfizer | 32 | $552 |
| Abbott | 9 | $401 |
| Lilly USA, LLC | 24 | $372 |
| Vifor Pharma, Inc. | 2 | $237 |
| Nestle Healthcare Nutrition Inc. | 9 | $180 |
| E.r. Squibb & Sons, L.L.C. | 10 | $163 |
| Melinta Therapeutics, LLC | 3 | $161 |
| Mylan Specialty L.p. | 9 | $127 |
| Teva Pharmaceuticals USA, Inc. | 2 | $114 |
| Astellas Pharma US Inc | 2 | $108 |
| Sanofi-aventis U.S. LLC | 1 | $91 |
| Sunovion Pharmaceuticals Inc. | 9 | $88 |
| Kowa Pharmaceuticals America, Inc. | 4 | $58 |
| Gilead | 4 | $46 |
| Shield Therapeutics Inc | 2 | $40 |
| Edwards Lifesciences | 1 | $39 |
| Novartis | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Inogen, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,644 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $15,075 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,367 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 42 | $1,065 |
| Atorvastatin Calcium | 83 | $1,040 |
| Rosuvastatin Calcium | 71 | $831 |
| Metoprolol Succinate | 51 | $825 |
| Losartan Potassium | 38 | $694 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 11 | $688 |
| Potassium Chloride | 29 | $668 |
| Allopurinol | 36 | $569 |
| Levothyroxine Sodium | 51 | $545 |
| FenofibrateFenofibrate Nanocrystallized | 15 | $519 |
| Metformin Hcl ErMetformin Hcl | 36 | $506 |
| Amlodipine Besylate | 76 | $492 |
| Metformin Hcl | 52 | $448 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $552 | $15,07513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Bartlett
- Mark McKenzieChattanooga$11.9M
- Bernard GrunstraBristol$6.4M
- Jewel WhiteKingsport$5.7M
- Judith WhiteKingsport$5.6M
- Obadias MarquezOoltewah$2.8M
- Amanda Moore MillerKnoxville$2.3M
- Rick WhilesBristol$1.5M
- John AndersonNashville$1.5M
- David MorinKingsport$1.4M
- John KirbyJefferson City$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.